BlackRock Institutional Trust’s vTv Therapeutics VTVT Stock Holding History

BlackRock Institutional Trust’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$359K	Sell	1,857 -421	-18%	-$96.8K	﹤0.01%	3509
2016 Q3	$655K	Sell	2,278 -133	-6%	-$32K	﹤0.01%	3420
2016 Q2	$559K	Buy	2,411 +453	+23%	+$104K	﹤0.01%	3473
2016 Q1	$404K	Sell	1,958 -54	-3%	-$13.4K	﹤0.01%	3505
2015 Q4	$548K	Buy	2,012 +340	+20%	+$95.4K	﹤0.01%	3494
2015 Q3	$436K	Buy	+1,672	New	+$583K	﹤0.01%	3524

Other funds holding VTVT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock Institutional Trust's VTVT Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its vTv Therapeutics (VTVT) stake by 18% in Q4 2016, selling an estimated $96.8K and leaving 1,857 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #3509.

BlackRock Institutional Trust first reported a position in VTVT in Q3 2015 and has held it in 6 quarters since. The position peaked at $655K in Q3 2016. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2016.

BlackRock Institutional Trust held 1,857 shares of vTv Therapeutics worth $359K as of Q4 2016.
BlackRock Institutional Trust sold 421 vTv Therapeutics shares in Q4 2016, an estimated $96.8K.
vTv Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3509 holding.
BlackRock Institutional Trust first reported a position in vTv Therapeutics in Q3 2015 and has held it in 6 quarters since.
BlackRock Institutional Trust's vTv Therapeutics position peaked at $655K in Q3 2016.
44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.